MKS Inc MKSI
MKS Inc., formerly known as MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”), was founded in 1961 as a Massachusetts corporation. 10-K, Item 1
- Headquarters
- Andover, MA
- CEO
- John Tseng-Chung Lee
- Next results
- around Jan 20, 2027
Where each dollar of revenue went, FY2025
Revenue of $3.9B through the costs to a net profit of $295.0M · income statement of the 10-K
MKSI among Technology peers
Six ratios from the latest 10-K. Each corner is the share of 230 peers the company is above, not a score.
What changed
19 new risk paragraphs. 10-K filed Feb 24, 2026 against Feb 25, 2025.
Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.
Accounting checks
11 checks on the latest 10-K. Checks, not verdicts.
0facts worth reading about all 11 checks found nothing to note
-
Receivables +5.9% ($615.0M to $651.0M) vs revenue +9.6% ($3.6B to $3.9B), -3.8 pts apart
-
Cash from operations $645.0M vs net income $295.0M (FY ending Dec 31, 2025)
-
Inventory +3.1% ($893.0M to $921.0M) vs revenue +9.6% ($3.6B to $3.9B), -6.5 pts apart
8 more checks with nothing to note
-
Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
-
No statement of substantial doubt about going concern
-
No 8-K item 4.02 in the last 2 years
-
No NT 10-K or NT 10-Q in the last 2 years
-
The same matters as last year: Revenue Recognition - Certain Product Revenue
-
No sentence in the 10-K concludes that controls were not effective because of a material weakness
-
No 8-K item 2.06 in the last 2 years
-
No 8-K item 1.03 in the last 2 years
In their words
19 paragraphs in Risk Factors that were not in the 10-K filed Feb 25, 2025. Quoted as filed.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
In addition, if we do not successfully complete acquisitions or integrate acquired businesses, we may need to re-evaluate our growth strategy. We may incur substantial expenses and devote significant management time and resources to complete acquisitions that may not generate the financial results we planned to achieve.
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Our ability to maintain and grow our business is directly related to our ability to hire, train, retain and motivate qualified employees, who we consider to be a significant asset. There is significant competition for personnel in the technology and sciences
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Emerging issues related to the development, deployment, and use of AI, including generative AI, in our business could give rise to competitive disadvantages, reputational harm, legal or regulatory action, or other adverse impacts on our business. We are in the early stages of integrating AI into our business and operational processes…
-
Item 1A · new paragraph · not in the 10-K filed Feb 25, 2025 10-K, ITEM 1A
Following a period of extreme escalation in early 2025, where U.S. duties on Chinese imports reached a peak of 145% (inclusive of a 125% reciprocal tariff and a 20% fentanyl-related surcharge), the trade environment has transitioned into a complex, multi-layered duty regime. As of January 2026, we remain subject to a combined 20%…
New risk paragraphs, against peers
Latest 10-K of each, Technology companies closest in revenue
Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.
Financial performance
Last 4 fiscal years · 10-K XBRL
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $3.5B | $3.6B | $3.6B | $3.9B |
| Net income | $333.0M | −$1.8B | $190.0M | $295.0M |
| Operating cash flow | $529.0M | $319.0M | $528.0M | $645.0M |
| Free cash flow | $365.0M | $232.0M | $410.0M | $497.0M |
Revenue, FY2016 to FY2025
Ten fiscal years, each from its own 10-K · XBRL · USD
$3.9B ▲ 9.6% in FY2025$295.0M ▲ 55.3% in FY2025$497.0M ▲ 21.2% in FY2025
Recent filings
7 filings in the last 30 days · SEC EDGAR
-
Planned saleNov 13, 2026Lee John Tseng-Chung (Officer, Director) gave notice of a planned sale of 10,000 shares worth about $2.2M Form 144, approximate sale date Nov 13, 2026, under a 10b5-1 plan adopted Feb 20, 2026
-
Planned saleNov 5, 2026Renee M. Donlan (Executive Vice President, General Counsel and Chief Compliance Officer) adopted a 10b5-1 trading plan reported in the 10-Q, up to 6,000 shares, runs to Aug 20, 2027
-
Planned saleNov 5, 2026Gerald G. Colella (Chairman of the Board of Directors) adopted a 10b5-1 trading plan reported in the 10-Q, up to 20,000 shares, runs to Nov 23, 2027
-
Planned saleNov 5, 2026Peter J. Cannone III (Director) adopted a 10b5-1 trading plan reported in the 10-Q, up to 2,000 shares, runs to May 11, 2027
-
10-QNov 5, 2026Quarterly report (10-Q) period ended Sep 30, 2026
About the company
MKS Inc, Andover, MA · from the 10-K filed Feb 24, 2026
MKS Inc., formerly known as MKS Instruments, Inc. (“MKS,” the “Company,” “our,” or “we”), was founded in 1961 as a Massachusetts corporation. We enable technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies.
- Headquarters
- Andover, MA
- Country
- United States
- Reports in
- USD
- Listed on
- Nasdaq
- Fiscal year ends
- December 31
- Last results
- Nov 4, 2026
- Incorporated in
- MA
Email alerts
Sources
The 10-K filed Feb 24, 2026 (open at SEC), compared with the 10-K filed Feb 25, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.
Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MKSI/export.csv") into a cell.